UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:GABRB3-FAF1 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: GABRB3-FAF1 | FusionPDB ID: 32119 | FusionGDB2.0 ID: 32119 | Hgene | Tgene | Gene symbol | GABRB3 | FAF1 | Gene ID | 2562 | 11124 |
Gene name | gamma-aminobutyric acid type A receptor subunit beta3 | Fas associated factor 1 | |
Synonyms | ECA5|EIEE43 | CGI-03|HFAF1s|UBXD12|UBXN3A|hFAF1 | |
Cytomap | 15q12 | 1p32.3 | |
Type of gene | protein-coding | protein-coding | |
Description | gamma-aminobutyric acid receptor subunit beta-3GABA-alpha receptor beta-2 subunitGABAA receptor beta-3 subunitgamma-aminobutyric acid (GABA) A receptor, beta 3gamma-aminobutyric acid A receptor beta 3gamma-aminobutyric acid type A receptor beta3 subu | FAS-associated factor 1Fas (TNFRSF6) associated factor 1TNFRSF6-associated factor 1UBX domain protein 3AUBX domain-containing protein 12UBX domain-containing protein 3A | |
Modification date | 20200320 | 20200313 | |
UniProtAcc | P28472 | Q9UNN5 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000299267, ENST00000311550, ENST00000541819, ENST00000557641, ENST00000400188, ENST00000545868, | ENST00000472808, ENST00000545823, ENST00000371778, ENST00000396153, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 9 X 9 X 2=162 | 28 X 23 X 14=9016 |
# samples | 9 | 31 | |
** MAII score | log2(9/162*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(31/9016*10)=-4.86214739489798 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: GABRB3 [Title/Abstract] AND FAF1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | GABRB3(27017548)-FAF1(51323670), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | GABRB3-FAF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. GABRB3-FAF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. GABRB3-FAF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. GABRB3-FAF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | GABRB3 | GO:0071420 | cellular response to histamine | 18281286 |
Hgene | GABRB3 | GO:1902476 | chloride transmembrane transport | 9039914 |
Hgene | GABRB3 | GO:1904862 | inhibitory synapse assembly | 25489750 |
Tgene | FAF1 | GO:0010942 | positive regulation of cell death | 15596450 |
Fusion gene breakpoints across GABRB3 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across FAF1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS5.0 | N/A | DA493815 | GABRB3 | chr15 | 27017548 | - | FAF1 | chr1 | 51323670 | - |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000311550 | GABRB3 | chr15 | 27017548 | - | ENST00000396153 | FAF1 | chr1 | 51323670 | - | 4222 | 352 | 112 | 2259 | 715 |
ENST00000311550 | GABRB3 | chr15 | 27017548 | - | ENST00000371778 | FAF1 | chr1 | 51323670 | - | 2663 | 352 | 112 | 2259 | 715 |
ENST00000541819 | GABRB3 | chr15 | 27017548 | - | ENST00000396153 | FAF1 | chr1 | 51323670 | - | 4381 | 511 | 76 | 2418 | 780 |
ENST00000541819 | GABRB3 | chr15 | 27017548 | - | ENST00000371778 | FAF1 | chr1 | 51323670 | - | 2822 | 511 | 76 | 2418 | 780 |
ENST00000299267 | GABRB3 | chr15 | 27017548 | - | ENST00000396153 | FAF1 | chr1 | 51323670 | - | 4174 | 304 | 1 | 2211 | 736 |
ENST00000299267 | GABRB3 | chr15 | 27017548 | - | ENST00000371778 | FAF1 | chr1 | 51323670 | - | 2615 | 304 | 1 | 2211 | 736 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000311550 | ENST00000396153 | GABRB3 | chr15 | 27017548 | - | FAF1 | chr1 | 51323670 | - | 0.00036881 | 0.99963117 |
ENST00000311550 | ENST00000371778 | GABRB3 | chr15 | 27017548 | - | FAF1 | chr1 | 51323670 | - | 0.000781183 | 0.9992188 |
ENST00000541819 | ENST00000396153 | GABRB3 | chr15 | 27017548 | - | FAF1 | chr1 | 51323670 | - | 0.000427758 | 0.9995722 |
ENST00000541819 | ENST00000371778 | GABRB3 | chr15 | 27017548 | - | FAF1 | chr1 | 51323670 | - | 0.000899266 | 0.9991008 |
ENST00000299267 | ENST00000396153 | GABRB3 | chr15 | 27017548 | - | FAF1 | chr1 | 51323670 | - | 0.000216905 | 0.9997831 |
ENST00000299267 | ENST00000371778 | GABRB3 | chr15 | 27017548 | - | FAF1 | chr1 | 51323670 | - | 0.000527843 | 0.9994722 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >32119_32119_1_GABRB3-FAF1_GABRB3_chr15_27017548_ENST00000299267_FAF1_chr1_51323670_ENST00000371778_length(amino acids)=736AA_BP=101 LAARRVGGRADPSRLGRRNSAMCSGLLELLLPIWLSWTLGTRGSEPRSVNDPGNMSFVKETVDKLLKGYDIRLRPDFGGPPVCVGMNIDI ASIDMVSEVNMACTGIENIDEAITLLEQNNWDLVAAINGVIPQENGILQSEYGGETIPGPAFNPASHPASAPTSSSSSAFRPVMPSRQIV ERQPRMLDFRVEYRDRNVDVVLEDTCTVGEIKQILENELQIPVSKMLLKGWKTGDVEDSTVLKSLHLPKNNSLYVLTPDLPPPSSSSHAG ALQESLNQNFMLIITHREVQREYNLNFSGSSTIQEVKRNVYDLTSIPVRHQLWEGWPTSATDDSMCLAESGLSYPCHRLTVGRRSSPAQT REQSEEQITDVHMVSDSDGDDFEDATEFGVDDGEVFGMASSALRKSPMMPENAENEGDALLQFTAEFSSRYGDCHPVFFIGSLEAAFQEA FYVKARDRKLLAIYLHHDESVLTNVFCSQMLCAESIVSYLSQNFITWAWDLTKDSNRARFLTMCNRHFGSVVAQTIRTQKTDQFPLFLII MGKRSSNEVLNVIQGNTTVDELMMRLMAAMEIFTAQQQEDIKDEDEREARENVKREQDEAYRLSLEADRAKREAHEREMAEQFRLEQIRK EQEEEREAIRLSLEQALPPEPKEENAEPVSKLRIRTPSGEFLERRFLASNKLQIVFDFVASKGFPWDEYKLLSTFPRRDVTQLDPNKSLL -------------------------------------------------------------- >32119_32119_2_GABRB3-FAF1_GABRB3_chr15_27017548_ENST00000299267_FAF1_chr1_51323670_ENST00000396153_length(amino acids)=736AA_BP=101 LAARRVGGRADPSRLGRRNSAMCSGLLELLLPIWLSWTLGTRGSEPRSVNDPGNMSFVKETVDKLLKGYDIRLRPDFGGPPVCVGMNIDI ASIDMVSEVNMACTGIENIDEAITLLEQNNWDLVAAINGVIPQENGILQSEYGGETIPGPAFNPASHPASAPTSSSSSAFRPVMPSRQIV ERQPRMLDFRVEYRDRNVDVVLEDTCTVGEIKQILENELQIPVSKMLLKGWKTGDVEDSTVLKSLHLPKNNSLYVLTPDLPPPSSSSHAG ALQESLNQNFMLIITHREVQREYNLNFSGSSTIQEVKRNVYDLTSIPVRHQLWEGWPTSATDDSMCLAESGLSYPCHRLTVGRRSSPAQT REQSEEQITDVHMVSDSDGDDFEDATEFGVDDGEVFGMASSALRKSPMMPENAENEGDALLQFTAEFSSRYGDCHPVFFIGSLEAAFQEA FYVKARDRKLLAIYLHHDESVLTNVFCSQMLCAESIVSYLSQNFITWAWDLTKDSNRARFLTMCNRHFGSVVAQTIRTQKTDQFPLFLII MGKRSSNEVLNVIQGNTTVDELMMRLMAAMEIFTAQQQEDIKDEDEREARENVKREQDEAYRLSLEADRAKREAHEREMAEQFRLEQIRK EQEEEREAIRLSLEQALPPEPKEENAEPVSKLRIRTPSGEFLERRFLASNKLQIVFDFVASKGFPWDEYKLLSTFPRRDVTQLDPNKSLL -------------------------------------------------------------- >32119_32119_3_GABRB3-FAF1_GABRB3_chr15_27017548_ENST00000311550_FAF1_chr1_51323670_ENST00000371778_length(amino acids)=715AA_BP=80 MWGLAGGRLFGIFSAPVLVAVVCCAQSVNDPGNMSFVKETVDKLLKGYDIRLRPDFGGPPVCVGMNIDIASIDMVSEVNMACTGIENIDE AITLLEQNNWDLVAAINGVIPQENGILQSEYGGETIPGPAFNPASHPASAPTSSSSSAFRPVMPSRQIVERQPRMLDFRVEYRDRNVDVV LEDTCTVGEIKQILENELQIPVSKMLLKGWKTGDVEDSTVLKSLHLPKNNSLYVLTPDLPPPSSSSHAGALQESLNQNFMLIITHREVQR EYNLNFSGSSTIQEVKRNVYDLTSIPVRHQLWEGWPTSATDDSMCLAESGLSYPCHRLTVGRRSSPAQTREQSEEQITDVHMVSDSDGDD FEDATEFGVDDGEVFGMASSALRKSPMMPENAENEGDALLQFTAEFSSRYGDCHPVFFIGSLEAAFQEAFYVKARDRKLLAIYLHHDESV LTNVFCSQMLCAESIVSYLSQNFITWAWDLTKDSNRARFLTMCNRHFGSVVAQTIRTQKTDQFPLFLIIMGKRSSNEVLNVIQGNTTVDE LMMRLMAAMEIFTAQQQEDIKDEDEREARENVKREQDEAYRLSLEADRAKREAHEREMAEQFRLEQIRKEQEEEREAIRLSLEQALPPEP -------------------------------------------------------------- >32119_32119_4_GABRB3-FAF1_GABRB3_chr15_27017548_ENST00000311550_FAF1_chr1_51323670_ENST00000396153_length(amino acids)=715AA_BP=80 MWGLAGGRLFGIFSAPVLVAVVCCAQSVNDPGNMSFVKETVDKLLKGYDIRLRPDFGGPPVCVGMNIDIASIDMVSEVNMACTGIENIDE AITLLEQNNWDLVAAINGVIPQENGILQSEYGGETIPGPAFNPASHPASAPTSSSSSAFRPVMPSRQIVERQPRMLDFRVEYRDRNVDVV LEDTCTVGEIKQILENELQIPVSKMLLKGWKTGDVEDSTVLKSLHLPKNNSLYVLTPDLPPPSSSSHAGALQESLNQNFMLIITHREVQR EYNLNFSGSSTIQEVKRNVYDLTSIPVRHQLWEGWPTSATDDSMCLAESGLSYPCHRLTVGRRSSPAQTREQSEEQITDVHMVSDSDGDD FEDATEFGVDDGEVFGMASSALRKSPMMPENAENEGDALLQFTAEFSSRYGDCHPVFFIGSLEAAFQEAFYVKARDRKLLAIYLHHDESV LTNVFCSQMLCAESIVSYLSQNFITWAWDLTKDSNRARFLTMCNRHFGSVVAQTIRTQKTDQFPLFLIIMGKRSSNEVLNVIQGNTTVDE LMMRLMAAMEIFTAQQQEDIKDEDEREARENVKREQDEAYRLSLEADRAKREAHEREMAEQFRLEQIRKEQEEEREAIRLSLEQALPPEP -------------------------------------------------------------- >32119_32119_5_GABRB3-FAF1_GABRB3_chr15_27017548_ENST00000541819_FAF1_chr1_51323670_ENST00000371778_length(amino acids)=780AA_BP=145 MAVSQVQSEMQQLRRLWVLAAQPFCHLPERCRLFFEIGGISLAMPQCLLWICLAVWEARGDLPFIAENDAVLTVNWNAVKEHRTFYAIYE TSVNDPGNMSFVKETVDKLLKGYDIRLRPDFGGPPVCVGMNIDIASIDMVSEVNMACTGIENIDEAITLLEQNNWDLVAAINGVIPQENG ILQSEYGGETIPGPAFNPASHPASAPTSSSSSAFRPVMPSRQIVERQPRMLDFRVEYRDRNVDVVLEDTCTVGEIKQILENELQIPVSKM LLKGWKTGDVEDSTVLKSLHLPKNNSLYVLTPDLPPPSSSSHAGALQESLNQNFMLIITHREVQREYNLNFSGSSTIQEVKRNVYDLTSI PVRHQLWEGWPTSATDDSMCLAESGLSYPCHRLTVGRRSSPAQTREQSEEQITDVHMVSDSDGDDFEDATEFGVDDGEVFGMASSALRKS PMMPENAENEGDALLQFTAEFSSRYGDCHPVFFIGSLEAAFQEAFYVKARDRKLLAIYLHHDESVLTNVFCSQMLCAESIVSYLSQNFIT WAWDLTKDSNRARFLTMCNRHFGSVVAQTIRTQKTDQFPLFLIIMGKRSSNEVLNVIQGNTTVDELMMRLMAAMEIFTAQQQEDIKDEDE REARENVKREQDEAYRLSLEADRAKREAHEREMAEQFRLEQIRKEQEEEREAIRLSLEQALPPEPKEENAEPVSKLRIRTPSGEFLERRF -------------------------------------------------------------- >32119_32119_6_GABRB3-FAF1_GABRB3_chr15_27017548_ENST00000541819_FAF1_chr1_51323670_ENST00000396153_length(amino acids)=780AA_BP=145 MAVSQVQSEMQQLRRLWVLAAQPFCHLPERCRLFFEIGGISLAMPQCLLWICLAVWEARGDLPFIAENDAVLTVNWNAVKEHRTFYAIYE TSVNDPGNMSFVKETVDKLLKGYDIRLRPDFGGPPVCVGMNIDIASIDMVSEVNMACTGIENIDEAITLLEQNNWDLVAAINGVIPQENG ILQSEYGGETIPGPAFNPASHPASAPTSSSSSAFRPVMPSRQIVERQPRMLDFRVEYRDRNVDVVLEDTCTVGEIKQILENELQIPVSKM LLKGWKTGDVEDSTVLKSLHLPKNNSLYVLTPDLPPPSSSSHAGALQESLNQNFMLIITHREVQREYNLNFSGSSTIQEVKRNVYDLTSI PVRHQLWEGWPTSATDDSMCLAESGLSYPCHRLTVGRRSSPAQTREQSEEQITDVHMVSDSDGDDFEDATEFGVDDGEVFGMASSALRKS PMMPENAENEGDALLQFTAEFSSRYGDCHPVFFIGSLEAAFQEAFYVKARDRKLLAIYLHHDESVLTNVFCSQMLCAESIVSYLSQNFIT WAWDLTKDSNRARFLTMCNRHFGSVVAQTIRTQKTDQFPLFLIIMGKRSSNEVLNVIQGNTTVDELMMRLMAAMEIFTAQQQEDIKDEDE REARENVKREQDEAYRLSLEADRAKREAHEREMAEQFRLEQIRKEQEEEREAIRLSLEQALPPEPKEENAEPVSKLRIRTPSGEFLERRF -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr15:27017548/chr1:51323670) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
GABRB3 | FAF1 |
FUNCTION: Ligand-gated chloride channel which is a component of the heteropentameric receptor for GABA, the major inhibitory neurotransmitter in the brain (PubMed:18514161, PubMed:22303015, PubMed:26950270, PubMed:22243422, PubMed:24909990). Plays an important role in the formation of functional inhibitory GABAergic synapses in addition to mediating synaptic inhibition as a GABA-gated ion channel (PubMed:25489750). The gamma2 subunit is necessary but not sufficient for a rapid formation of active synaptic contacts and the synaptogenic effect of this subunit is influenced by the type of alpha and beta subunits present in the receptor pentamer (By similarity). The alpha1/beta3/gamma2 receptor exhibits synaptogenic activity (PubMed:25489750). The alpha2/beta3/gamma2 receptor shows very little or no synaptogenic activity (By similarity). Functions also as histamine receptor and mediates cellular responses to histamine (PubMed:18281286). Plays an important role in somatosensation and in the production of antinociception (By similarity). {ECO:0000250|UniProtKB:P63080, ECO:0000269|PubMed:18281286, ECO:0000269|PubMed:18514161, ECO:0000269|PubMed:22243422, ECO:0000269|PubMed:22303015, ECO:0000269|PubMed:24909990, ECO:0000269|PubMed:25489750, ECO:0000269|PubMed:26950270}. | FUNCTION: Ubiquitin-binding protein (PubMed:19722279). Required for the progression of DNA replication forks by targeting DNA replication licensing factor CDT1 for degradation (PubMed:26842564). Potentiates but cannot initiate FAS-induced apoptosis (By similarity). {ECO:0000250|UniProtKB:P54731, ECO:0000269|PubMed:19722279, ECO:0000269|PubMed:26842564}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | FAF1 | chr15:27017548 | chr1:51323670 | ENST00000371778 | 1 | 20 | 569_646 | 15.0 | 651.0 | Domain | UBX | |
Tgene | FAF1 | chr15:27017548 | chr1:51323670 | ENST00000396153 | 0 | 19 | 569_646 | 15.0 | 651.0 | Domain | UBX |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000299267 | - | 3 | 9 | 120_122 | 80.0 | 474.0 | Region | Note=Agonist binding |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000299267 | - | 3 | 9 | 180_182 | 80.0 | 474.0 | Region | Note=Agonist binding |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000299267 | - | 3 | 9 | 290_311 | 80.0 | 474.0 | Region | Note=Allosteric effector binding |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000311550 | - | 3 | 9 | 120_122 | 80.0 | 474.0 | Region | Note=Agonist binding |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000311550 | - | 3 | 9 | 180_182 | 80.0 | 474.0 | Region | Note=Agonist binding |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000311550 | - | 3 | 9 | 290_311 | 80.0 | 474.0 | Region | Note=Allosteric effector binding |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000400188 | - | 1 | 7 | 120_122 | 0 | 403.0 | Region | Note=Agonist binding |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000400188 | - | 1 | 7 | 180_182 | 0 | 403.0 | Region | Note=Agonist binding |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000400188 | - | 1 | 7 | 290_311 | 0 | 403.0 | Region | Note=Allosteric effector binding |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000545868 | - | 1 | 7 | 120_122 | 0 | 389.0 | Region | Note=Agonist binding |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000545868 | - | 1 | 7 | 180_182 | 0 | 389.0 | Region | Note=Agonist binding |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000545868 | - | 1 | 7 | 290_311 | 0 | 389.0 | Region | Note=Allosteric effector binding |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000299267 | - | 3 | 9 | 268_270 | 80.0 | 474.0 | Topological domain | Cytoplasmic |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000299267 | - | 3 | 9 | 26_245 | 80.0 | 474.0 | Topological domain | Extracellular |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000299267 | - | 3 | 9 | 294_304 | 80.0 | 474.0 | Topological domain | Extracellular |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000299267 | - | 3 | 9 | 328_450 | 80.0 | 474.0 | Topological domain | Cytoplasmic |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000311550 | - | 3 | 9 | 268_270 | 80.0 | 474.0 | Topological domain | Cytoplasmic |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000311550 | - | 3 | 9 | 26_245 | 80.0 | 474.0 | Topological domain | Extracellular |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000311550 | - | 3 | 9 | 294_304 | 80.0 | 474.0 | Topological domain | Extracellular |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000311550 | - | 3 | 9 | 328_450 | 80.0 | 474.0 | Topological domain | Cytoplasmic |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000400188 | - | 1 | 7 | 268_270 | 0 | 403.0 | Topological domain | Cytoplasmic |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000400188 | - | 1 | 7 | 26_245 | 0 | 403.0 | Topological domain | Extracellular |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000400188 | - | 1 | 7 | 294_304 | 0 | 403.0 | Topological domain | Extracellular |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000400188 | - | 1 | 7 | 328_450 | 0 | 403.0 | Topological domain | Cytoplasmic |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000545868 | - | 1 | 7 | 268_270 | 0 | 389.0 | Topological domain | Cytoplasmic |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000545868 | - | 1 | 7 | 26_245 | 0 | 389.0 | Topological domain | Extracellular |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000545868 | - | 1 | 7 | 294_304 | 0 | 389.0 | Topological domain | Extracellular |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000545868 | - | 1 | 7 | 328_450 | 0 | 389.0 | Topological domain | Cytoplasmic |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000299267 | - | 3 | 9 | 246_267 | 80.0 | 474.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000299267 | - | 3 | 9 | 271_293 | 80.0 | 474.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000299267 | - | 3 | 9 | 305_327 | 80.0 | 474.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000299267 | - | 3 | 9 | 451_472 | 80.0 | 474.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000311550 | - | 3 | 9 | 246_267 | 80.0 | 474.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000311550 | - | 3 | 9 | 271_293 | 80.0 | 474.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000311550 | - | 3 | 9 | 305_327 | 80.0 | 474.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000311550 | - | 3 | 9 | 451_472 | 80.0 | 474.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000400188 | - | 1 | 7 | 246_267 | 0 | 403.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000400188 | - | 1 | 7 | 271_293 | 0 | 403.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000400188 | - | 1 | 7 | 305_327 | 0 | 403.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000400188 | - | 1 | 7 | 451_472 | 0 | 403.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000545868 | - | 1 | 7 | 246_267 | 0 | 389.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000545868 | - | 1 | 7 | 271_293 | 0 | 389.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000545868 | - | 1 | 7 | 305_327 | 0 | 389.0 | Transmembrane | Note=Helical |
Hgene | GABRB3 | chr15:27017548 | chr1:51323670 | ENST00000545868 | - | 1 | 7 | 451_472 | 0 | 389.0 | Transmembrane | Note=Helical |
Tgene | FAF1 | chr15:27017548 | chr1:51323670 | ENST00000371778 | 1 | 20 | 1_57 | 15.0 | 651.0 | Domain | UBA | |
Tgene | FAF1 | chr15:27017548 | chr1:51323670 | ENST00000396153 | 0 | 19 | 1_57 | 15.0 | 651.0 | Domain | UBA |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
GABRB3 | |
FAF1 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to GABRB3-FAF1 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to GABRB3-FAF1 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |